The company’s investors include the founding management team, the venture fund BioAdvance and the Lankenau Institute for Medical Research, where the company’s molecular biology laboratory is located.

BioAdvance ( is an early-stage life sciences fund that works with entrepreneurs in the mid-Atlantic region to build strong companies that have the potential to improve human health.

The Lankenau Institute for Medical Research ( is a major independent, nonprofit biomedical research center located in suburban Philadelphia on the campus of Lankenau Medical Center, part of Main Line Health. 

To learn more about RiboNova, please email us by clicking below:

​© 2020 RiboNova

RiboNova is a registered trademark of RiboNova Inc.